A study of Sonlicromanol for post-COVID patients
Part of Infections, Lungs & breathing clinical trials.
This trial tests a medicine called Sonlicromanol to see if it helps people with lingering symptoms after a mild case of COVID-19. It is for people who have post-exertional malaise (feeling very tired or worse after activity) and a moderate level of disability.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of post-COVID from a doctor.
- You need to have post-exertional malaise, meaning you feel much worse after even small amounts of activity.
- Your daily function should be at 20-70% of normal, as measured by a standard disability scale.
- Your first COVID-19 infection was mild and did not require a hospital stay.
- You were in good health (fully active) before getting COVID-19.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different treatments for long COVID (PCC) symptoms like fatigue and brain fog that started after a COVID infection. It aims to find which treatments help people recover.
This trial is testing treatments for people with long COVID, which is when symptoms last more than 3 months after a COVID-19 infection. The trial focuses on three specific symptom groups: heart inflammation, cough, or severe fatigue with signs of inflammation. It aims to find if certain immune-modulating therapies can help.
This trial tests if a low dose of sirolimus, a medicine that calms the immune system, can help people with long COVID. If you have had long COVID symptoms for at least 6 months, like severe fatigue, brain fog, or chest pain, you may be able to join.
This trial tests a natural compound to see if it can reduce ongoing inflammation and symptoms like fatigue, brain fog, or shortness of breath that linger after a COVID-19 infection. It's for people who still have symptoms at least 2 months after getting sick.
This trial tests a new medicine, sonlicromanol, for people with a specific type of mitochondrial disease (caused by the m.3243A>G mutation) who also have chronic fatigue and muscle weakness. The goal is to see if it helps improve symptoms and daily function.
This trial tests a program to help people with lingering COVID-19 symptoms who are not very active. It aims to improve their health and daily life.
Hear when a new Post-COVID Condition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.